[151 Pages Report]The hernia repair market is projected to reach USD 4.75 billion by 2023 from USD 4.09 billion in 2018, at a CAGR of 3.0% during the forecast period. The increasing adoption of mesh in hernia repair surgeries, rising geriatric population, new product developments, and efficient reimbursement system in developed countries are the major factors driving the growth of the hernia repair market during the forecast period.

Helped the leading service provider to expand into USD 2.5 billion hernia mesh products market with and expected revenue growth of 125 million across target countries Client�s Problem Statement Our client, a key provider of hernia repair surgery was keen to know about the revenue generated through hernia mesh fixation procedures utilizing glue & tack applicators as well as various factors affecting the market such as individual growth trends and future prospects for herniamesh fixation and hernia mesh repair products. The client wanted insights in countries such as the US, Canada, Germany, France, the UK, Spain, Italy, Japan, China, and India. MnM Approach MnM started by identifying the total number of hernia repair surgeries performed. The data was broken down into the number of procedures performed using tac, tac applicator, and glue. Country-level data was identified and further split into surgeries by biological mesh and synthetic mesh. MnM also interviewed key service providers, vendors, and distributors to confirm the sales and the split of surgeries performed. Through this, MnM was able to provide its client an in-depth understanding of the sales of hernia mesh repair products in each country: the US, Canada, Germany, France, the UK, Spain, Italy, Japan, China, and India. Further, MnM also helped the client obtain a better understanding of the number of open hernia repair and laparoscopic hernia repair surgeries using tac, tac applicator, and glue in each country. Revenue Impact (RI) Helped the leading service provider to expand into USD 2.5 billion hernia mesh products market with and expected revenue growth of 125 million across target countries. Consult our Analyst now

By product, the mesh fixators segment is expected to grow at the highest rate during the forecast period

On the basis of product, the hernia repair market is segmented into mesh and mesh fixators. A mesh is used for reinforcing weak spots in the muscle while repairing the hernia. Mesh fixators are used to fix the mesh in its place to avoid displacement. In 2018, the hernia mesh fixators segment is expected to grow at the highest CAGR during the forecast period. This significant growth of the segment is attributed to the rising adoption of surgical glue as mesh fixators.

The hernia mesh segment is further categorized on the basis of type and surgery. On the basis of type, this market is segmented into synthetic and biologic mesh. In 2018, the biologic mesh segment is expected to register the highest growth rate in the hernia mesh market. The increasing number of clinical trials to establish safety and the benefits of biologic meshes coupled with technological advancements to reduce �could be� issues with these mesh are some of the factors triggering the growth of this segment.

The hernia mesh fixators market is segmented into sutures, tack applicators, and glue applicators. Among these, sutures are the most common type of mesh fixator, followed by tack applicators. However, due to the higher price of tacks, the tack applicators segment is expected to account for the largest share in the mesh fixators market in 2018. While the rising adoption of surgical glue as mesh fixators makes glue applicators the fastest growing segment in the mesh fixators market.

By surgery type, the inguinal hernia segment is expected to be the largest contributor to the hernia mesh market in 2018

Based on surgery, the hernia mesh market is segmented into inguinal hernia, incisional/ventral hernia, femoral hernia, and umbilical hernia. Of these, the inguinal hernia segment is expected to account for the largest market share in 2018. The large share of this segment is attributed to the high number of inguinal hernia repair surgeries performed worldwide every year.

North America dominated the market in 2017

Geographically, the global hernia repair market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World (RoW). In 2017, North America was the largest market for hernia mesh devices. The large share of North America in this market can be attributed to the strong demand for and adoption of hernia repair in the US. The adoption of hernia mesh devices, particularly biologic mesh devices, is the highest in the US. As these devices are priced at a premium, their high demand is resulting in large revenue generation for companies operating in the US. In addition, the majority of prominent market players operate in the North American market owing to which the access to new and advanced hernia repair is high in this regional market. Also, other factors such as the presence of a large pool of hernia patients and an efficient and favorable healthcare system are supporting the growth of the hernia repair market in North America.

However, the high cost of meshes, long waiting times, and the development of non-mesh repair approaches are restraining the growth of this market.

Market Dynamics

The increasing number of hernia repair procedures, advantages of mesh in hernia repair, and technological advancements are the major factors driving the hernia repair market. In addition, emerging markets are expected to emerge as potential areas of opportunity for players in this market.

However, the high cost of meshes, long waiting times, and the development of non-mesh repair approaches are restraining the growth of this market. In addition, increasing pricing pressure on market players and the need for skilled personnel to conduct laparoscopic surgery are the key challenges faced in this industry.

Driver: Increasing hernia prevalence

The growing prevalence of hernia is the main driving force for the growth of the hernia mesh repair market. This is mainly attributed to the overall increase in population, specifically geriatric and obese population, and improvements in healthcare systems that have enabled the early detection and treatment of hernia.

Age contributes significantly to the risk of hernia by retarding the body�s capabilities and natural healing abilities over time. According to a registered study in the UK, the prevalence of hernia was found to increase with age, from 5% in the 25�V34 age group to:

10% in the 35-44 age group

18% in the 45-54 age group

24% in the 55-64 age group

31% in the 65-74 age group

In addition, the incidence of hernia among men aged 75 years and above was found to be 45%. Consequently, the growth in aging population can be expected to boost overall hernia incidence in the coming years.

Restraint: High Cost of mesh repair and availability of less-expensive approaches

While mesh repair is relatively common in developed countries, meshes are still too expensive to be used on a regular basis in developing markets. For example, in African countries, only 8-10% hernias are repaired with meshes mainly due to the higher cost of mesh repair (Source: �Mesh versus non-mesh for inguinal and femoral hernia repair (Protocol),� published in The Cochrane Laboratory, 2015). Typically, the first-generation mesh is commonly used. On the whole, hernia mesh repair with advanced products is unaffordable in countries with a per capita government healthcare expenditure below USD 50, whereas the price of the mesh is USD 100�3,000 (and above).

A shift in the decision-making process in hospitals, from surgeons and nurses to hospital administrators and accountants, has also slowed the greater adoption of more effective but expensive medical devices and technologies. As a result, most hospitals perform a cost-benefit analysis before implementing any new surgical instruments, implants, or procedures as a cost-containment measure. Consequently, in such markets, the higher cost of technologically advanced surgical products poses a challenge to their adoption.

Scope of the Report

Report Metric Details Market Size Available for Years 2016�2023 Base Year Considered 2017 Forecast Period 2018�2023 Forecast Units Value (USD) Segments Covered Product, surgery, and region Geographies Covered North America (US & Canada), Europe (Germany, France, UK, and RoE), APAC (Japan, China, India, and RoAPAC), and the RoW Companies Covered Covidien Plc (Medtronic Plc) (Ireland), Ethicon (Johnson & Johnson Services, Inc.) (US), B. Braun Melsungen AG (Germany), C.R. Bard (Becton, Dickinson and Company) (US), W. L. Gore & Associates (US), LifeCell Corporation (Allergan) (Ireland), Maquet (Getinge AB) (Sweden), Cook Medical (US), and Integra Lifesciences (US). Other players include DIPROMED (Italy), FEG Textiltechnik mbH (Germany), Cousin Biotech (France), Herniamesh (Italy), Aspide Medical (France), TransEasy Medical (China), and Via Surgical (Israel). Major 15 players covered.

This report categorizes the hernia repair market into the following segments and subsegments:

Hernia repair Market, by Product

Hernia Mesh Synthetic Mesh Biologic Mesh

Mesh Fixator Sutures Tack Applicators Glue Applicators



Hernia Mesh Market, by Surgery Type

Inguinal Hernia Repair

Incisional/Ventral Hernia Repair

Umbilical Hernia Repair

Femoral Hernia Repair

Hernia repair Market, by Procedure Type

Laparoscopic Procedure

Open/conventional Procedure

Hernia repair Market, by Region

North America US Canada

Europe Germany France UK Rest of Europe

Asia Pacific Japan China India Rest of Asia Pacific

Rest of the World

Key Market Players

The major players in the hernia repair market profiled in this report are Covidien Plc (Medtronic Plc) (Ireland), Ethicon (Johnson & Johnson Services, Inc.) (US), B. Braun Melsungen AG (Germany), C.R. Bard (Becton, Dickinson and Company) (US), W. L. Gore & Associates (US), LifeCell Corporation (Allergan) (Ireland), Maquet (Getinge AB) (Sweden), Cook Medical (US), and Integra Lifesciences (US). Other players include DIPROMED (Italy), FEG Textiltechnik mbH (Germany), Cousin Biotech (France), Herniamesh (Italy), Aspide Medical (France), TransEasy Medical (China), and Via Surgical (Israel).

Medtronic has a well-diversified business and strong geographic presence in the market. The company has a strong presence in the US market and is expanding its reach in emerging markets. For instance, in 2016, the company opened its regional headquarters in Singapore to improve its market presence in the Asia Pacific market.

Medtronic offers hernia repair products through its subsidiary�Covidien. Covidien offers synthetic monofilament meshes, composite meshes, and biologic meshes. The company also offers tack applicators for mesh fixation. Medtronic offers its mesh fixation tacks under the brand name�ProTack.

Johnson & Johnson (US): Johnson & Johnson offers its hernia repair products through its subsidiary� Ethicon. The hernia repair and fixation segment offers absorbable strap fixation devices, open absorbable strap fixation devices; polypropylene hernia systems and plugs; hernia meshes including absorbable lightweight meshes, soft polypropylene meshes, polypropylene meshes, and woven meshes; tissue separating meshes including flexible composite meshes, surgical meshes, ventral patches, and open flexible composite mesh devices; and biologic meshes including tissue matrix and acellular hydrated dermis.

With its diverse product portfolio and focus on R&D and product launches, the company is among the leading market players in the hernia repair market. It has a strong presence in the global medical devices market and is the sixth largest biotech and consumer healthcare company.

Like J&J, Ethicon also has a diverse product portfolio, and more than 600 general surgical products of the company are listed in the US FDA. Most of these products have patent exclusivity in the US beyond 2020, which will help the company sustain its market position. Ethicon harnesses J&J�s worldwide infrastructure to sell its products. Ethicon also gets benefited through synergies with its parent company in R&D, technological know-how, business strategies, and project implementation experience.

Recent Developments:

In 2017, BD acquired C. R. Bard. With this acquisition, BD entered the hernia repair business. The acquisition is expected to help C. R. Bard to increase its geographic presence in terms of both�sales and operations and maintain its market position.

In 2017, Allergan acquired LifeCell Corporation. This acquisition expanded its medical aesthetic products portfolio by the addition of ALLODERM and STRATTICE.

In June 2017, W. L. Gore GORE launched SYNECOR Preperitoneal Biomaterial. The newly launched product helped the company to broaden its product offerings in the hernia market

In 2016, B. Braun opened its new subsidiary in Zambia named �B. Braun Medical Zambia Limited� which will help the company to establish a strong foothold in Southern Africa.

Key questions addressed in the report:

What are the growth opportunities related to hernia repair market across major regions in the future?

Emerging countries have immense opportunities for the growth and adoption of hernia repair products. Will this scenario continue in the next five years?

What are the various hernia repair product segments and their market share in the overall market?

What are the new trends and advancements in the hernia mesh market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst